The American Cancer Society recently updated its colorectal cancer screening guideline for the first time since 2018 by ...
A young boy from Kenya battled aggressive bladder rhabdomyosarcoma since early childhood. Doctors initially offered little ...
The FDA has approved two immunotherapy combination therapies for adults with muscle-invasive bladder cancer. Pembrolizumab ...
The Food and Drug Administration approved a combination treatment by Merck & Co., Pfizer, and Astellas Pharma for a hard-to-treat form of bladder cancer. The agency greenlit Merck's Keytruda and its ...
On Friday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE and Astellas Pharma Inc.’s ALPMF ALPMY ...
Men had a higher likelihood than women for late-stage diagnosis of 20 different types of cancer, data from a national ...
The platform, including the assay, specimen collection kit, and associated software, underwent a comprehensive review including evidence of analytical and clinical validity.
OSLO, Norway, June 8, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The ...
Bladder cancer continues to be one of the most frequently diagnosed malignancies worldwide, with current treatments such as surgery and chemotherapy often ...
IND clearance allows initiation of a Q4 2026 phase 1 NMIBC study evaluating intravesical UGN-501 safety, tolerability, and administration feasibility. Recurrence remains common in NMIBC, especially ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results